There are significant implications to the to the potential rescheduling of cannabis by the U.S. Drug Enforcement Administration (DEA). The DEA announced on April 30 that it would begin the rulemaking process to reschedule cannabis to align with the Department of Health and Human Series (HHS) recommendations.
Industry-wide, there has been rampant speculation about what the policy move will mean for various segments of the pan-cannabis sector. Even though hemp is separately defined and theoretically discrete from recreational and medical MJ, there are some potential benefits for these operators.
…
11.21.2024
Domestic US biodiesel blending helps lift October RFS RIN production
US domestic biodiesel blending of 147.5 million gallons in October produced a monthly high of 221.2 million renewable identification number (RIN) credits for January-October. This was 11.5% above September...
11.21.2024
CWG trades lower as broader animal fats markets hold steady
The US animal fats and oils markets held steady on Thursday November 21, with limited trading as attention shifted toward broader macroeconomic factors and...
11.21.2024
October commercial cattle, hog production above 2023
US animal protein prices were steady on Thursday November 21. Limited trade was reported from market sources due to the proximity of the extended Thanksgiving holiday weekend in the...